Daratumumab/lenalidomideInfusion related reaction and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1840卷 / 1期

关键词：

D O I：

10.1007/s40278-021-90286-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：143 / 143

相关论文

共 50 条

[1] AlemtuzumabInfusion related reaction and lack of efficacy: case report
Reactions Weekly, 2023, 1967 (1) : 26 - 26
[2] Daratumumab/ixazomib/lenalidomideVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2022, 1929 (1) : 233 - 233
[3] Multiple drugInfusion related reaction and lack of efficacy: case report
Reactions Weekly, 2023, 1984 (1) : 348 - 348
[4] Daratumumab/dexamethasone/tobramycinChoroidal effusion and Lack of efficacy: case report
Reactions Weekly, 2023, 1954 (1) : 176 - 176
[5] Daratumumab/itraconazole/lenalidomideGastrointestinal histoplasmosis and lack of efficacy : case report
Reactions Weekly, 2024, 2019 (1) : 148 - 148
[6] Daratumumab/dexamethasone/methylprednisoloneCiliochoroidal effusions and lack of efficacy: case report
Reactions Weekly, 2021, 1856 (1) : 166 - 166
[7] Multiple drugsInfusion-related reaction and lack of efficacy: case report
Reactions Weekly, 2022, 1924 (1) : 303 - 303
[8] Multiple drugsInfusion-related reaction and lack of efficacy: case report
Reactions Weekly, 2023, 1947 (1) : 282 - 282
[9] AntineoplasticsHypersensitivity reaction and lack of efficacy: case report
Reactions Weekly, 2022, 1906 (1) : 62 - 62
[10] TozinameranInflammatory reaction and lack of efficacy: case report
Reactions Weekly, 2023, 1961 (1) : 394 - 394

← 1 2 3 4 5 →